Drug Therapy for the Elderly

  • Martin Wehling

Table of contents

  1. Front Matter
    Pages i-xv
  2. General Aspects

  3. Special Aspects with Respect to Organ Systems Based on Geriatric Clinical Importance

    1. Front Matter
      Pages 51-51
    2. Martin Wehling
      Pages 53-68
    3. Martin Wehling, Robert Lee Page 2nd
      Pages 69-83
    4. Martin Wehling
      Pages 85-103
    5. Martin Wehling
      Pages 105-118
    6. Heinrich Burkhardt
      Pages 119-134
    7. Martin Wehling
      Pages 135-142
    8. Martin Wehling
      Pages 143-150
    9. Heinrich Burkhardt
      Pages 151-160
    10. Heinrich Burkhardt
      Pages 161-178
    11. Stefan Schwarz, Lutz Frölich
      Pages 179-196
    12. Stefan Schwarz, Lutz Frölich
      Pages 197-213
    13. Stefan Schwarz, Lutz Frölich
      Pages 215-227

About this book

Introduction

With people aged 65 years and older currently making up the fastest growing age group throughout the world, the demographic revolution of an aging society will inevitably lead to increased pressure to develop a rationalistic and age-tailored process of diagnosis and treatment among the elderly. As aging people often suffer from several chronic diseases and are being treated with multiple medications concurrently, unwanted drug interactions occur more frequently.

Whereas recent approaches have recommended to remove particular drugs from the medication regimen to avoid adverse effects, Drug Therapy for the Elderly underlines both indispensable and dispensable elements of drug treatment, providing the practitioner with:
- Background information on the elderly population regarding their needs for particular drugs (with an eye to frailty, co-morbidity patterns, and special sensitivities regarding drug metabolism and excretion)
- Practical advice about drug treatment surveillance parameters in the elderly
- In-depth discussion of drugs in relation to the elderly with specific diagnoses
- Integration of multimorbidity/polypharmacy situations into prioritization schemes
- A plan for how to deal with the complexity of polypharmacy situations in a five-minute consultation


An original classification of drugs is proposed by the editor which relates the power of effects, prognostic data, and tolerability to a prioritization scoring system. This approach is the first to not only provide a negative listing, but also integrates positive data into an overall assessment for drugs fit for the aged. Therefore, Drug Therapy for the Elderly serves as a timely reference for a wide array of physicians.

Keywords

Drug Therapy Elderly Geriatrics Multimorbidity Pharmacotherapy Polypharmacy Serious adverse effects

Editors and affiliations

  • Martin Wehling
    • 1
  1. 1.Inst. Klinische PharmakologieKlinikum Stadt Mannheim gGmbHMannheimGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-7091-0912-0
  • Copyright Information Springer-Verlag Wien 2013
  • Publisher Name Springer, Vienna
  • eBook Packages Medicine
  • Print ISBN 978-3-7091-0911-3
  • Online ISBN 978-3-7091-0912-0
  • About this book